These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34341792)

  • 21. Expiratory Aerosol pH: The Overlooked Driver of Airborne Virus Inactivation.
    Luo B; Schaub A; Glas I; Klein LK; David SC; Bluvshtein N; Violaki K; Motos G; Pohl MO; Hugentobler W; Nenes A; Krieger UK; Stertz S; Peter T; Kohn T
    Environ Sci Technol; 2023 Jan; 57(1):486-497. PubMed ID: 36537693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simulating near-field enhancement in transmission of airborne viruses with a quadrature-based model.
    Fierce L; Robey AJ; Hamilton C
    Indoor Air; 2021 Nov; 31(6):1843-1859. PubMed ID: 34297863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerosol Transmission of SARS-CoV-2: Physical Principles and Implications.
    Jarvis MC
    Front Public Health; 2020; 8():590041. PubMed ID: 33330334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dynamics of SARS-CoV-2 infectivity with changes in aerosol microenvironment.
    Oswin HP; Haddrell AE; Otero-Fernandez M; Mann JFS; Cogan TA; Hilditch TG; Tian J; Hardy DA; Hill DJ; Finn A; Davidson AD; Reid JP
    Proc Natl Acad Sci U S A; 2022 Jul; 119(27):e2200109119. PubMed ID: 35763573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A spatiotemporally resolved infection risk model for airborne transmission of COVID-19 variants in indoor spaces.
    Li X; Lester D; Rosengarten G; Aboltins C; Patel M; Cole I
    Sci Total Environ; 2022 Mar; 812():152592. PubMed ID: 34954184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters.
    Mohandas S; Yadav PD; Shete A; Nyayanit D; Sapkal G; Lole K; Gupta N
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters.
    Port JR; Yinda CK; Owusu IO; Holbrook M; Fischer R; Bushmaker T; Avanzato VA; Schulz JE; Martens C; van Doremalen N; Clancy CS; Munster VJ
    Nat Commun; 2021 Aug; 12(1):4985. PubMed ID: 34404778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlling risk of SARS-CoV-2 infection in essential workers of enclosed food manufacturing facilities.
    Sobolik JS; Sajewski ET; Jaykus LA; Cooper DK; Lopman BA; Kraay ANM; Ryan PB; Leon JS
    Food Control; 2022 Mar; 133():108632. PubMed ID: 34703082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection.
    Adenaiye OO; Lai J; Bueno de Mesquita PJ; Hong F; Youssefi S; German J; Tai SHS; Albert B; Schanz M; Weston S; Hang J; Fung C; Chung HK; Coleman KK; Sapoval N; Treangen T; Berry IM; Mullins K; Frieman M; Ma T; Milton DK
    Clin Infect Dis; 2022 Aug; 75(1):e241-e248. PubMed ID: 34519774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the concentration of SARS-CoV-2 in outdoor air and the interaction with pre-existing atmospheric particles.
    Belosi F; Conte M; Gianelle V; Santachiara G; Contini D
    Environ Res; 2021 Feb; 193():110603. PubMed ID: 33307081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model.
    Frise R; Baillon L; Zhou J; Kugathasan R; Peacock TP; Brown JC; Samnuan K; McKay PF; Shattock RJ; Barclay WS
    Vaccine; 2022 May; 40(20):2848-2855. PubMed ID: 35396165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimum Sizes of Respiratory Particles Carrying SARS-CoV-2 and the Possibility of Aerosol Generation.
    Lee BU
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters.
    Port JR; Yinda CK; Riopelle JC; Weishampel ZA; Saturday TA; Avanzato VA; Schulz JE; Holbrook MG; Barbian K; Perry-Gottschalk R; Haddock E; Martens C; Shaia CI; Lambe T; Gilbert SC; van Doremalen N; Munster VJ
    Nat Commun; 2023 Oct; 14(1):6592. PubMed ID: 37852960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher viral load and infectivity increase risk of aerosol transmission for Delta and Omicron variants of SARS-CoV-2.
    Riediker M; Briceno-Ayala L; Ichihara G; Albani D; Poffet D; Tsai DH; Iff S; Monn C
    Swiss Med Wkly; 2022 Jan; 152():w30133. PubMed ID: 35019196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased pathogenicity and aerosol transmission for one SARS-CoV-2 B.1.617.2 Delta variant over the wild-type strain in hamsters.
    Zhang X; Chen S; Cao Z; Yao Y; Yu J; Zhou J; Gao G; He P; Dong Z; Zhong J; Luo J; Wei H; Zhang H
    Virol Sin; 2022 Dec; 37(6):796-803. PubMed ID: 36182073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a new Aerosol Barrier Mask for mitigation of spread of SARS-CoV-2 and other infectious pathogens.
    Karam KA; Hota P; Mora SJ; Lowell A; McKay K; Xian X; Patel B; Forzani E
    medRxiv; 2021 Feb; ():. PubMed ID: 33594375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breathing, speaking, coughing or sneezing: What drives transmission of SARS-CoV-2?
    Stadnytskyi V; Anfinrud P; Bax A
    J Intern Med; 2021 Nov; 290(5):1010-1027. PubMed ID: 34105202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of respiratory droplet physicochemistry in limiting and promoting the airborne transmission of human coronaviruses: A critical review.
    Niazi S; Groth R; Spann K; Johnson GR
    Environ Pollut; 2021 May; 276():115767. PubMed ID: 33243541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients.
    Ong DSY; de Man P; Verhagen T; Doejaaren G; Dallinga MA; Alibux E; Janssen ML; Wils EJ
    J Med Virol; 2023 Apr; 95(4):e28748. PubMed ID: 37185846
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.